Fibrosarcoma Market Forecast, Trend Analysis & Competition Tracking - Global Market insights 2017 to 2026

  • Published : Dec-2017
  • Tables : 141
  • Figures : 87
  • Category : Healthcare
  • No. of Pages : 170
  • Report Code : FACT353MR
  • Format : ppt

Fibrosarcoma is cancer, which is a part of larger collection of cancers known as sarcomas. Fibrosarcoma is generally treated with the help of chemotherapy. Meanwhile, some fibrosarcoma is not treatable with chemotherapy, especially in the case where cancer has spread to the parts like liver. In order to treat such type of cancers, researchers are focusing on developing targeted therapies. These targeted therapies attempt to capitalize on the biological characteristic of a cancer cell to eradicate the tumor. This is the factor that will make targeted therapy more effective than the traditional treatments. There are two important reasons for the development of targeted therapy. One is that it targets only cancer cells and kills it, while normal cells can spread. Second is that it provides effective treatment with minimum side-effects. Pharmaceutical companies are also focusing on research and development of drugs that can be effective in the treatment of fibrosarcoma and other types of sarcomas.

global fibrosarcoma market

As per the new report by Fact.MR, the global fibrosarcoma market is likely to witness steady growth between 2017 and 2026. The market is estimated to reach US$ 442.4 million revenue by 2026 end. Owing to the increasing prevalence of cancer, the use of cancer treatment drugs along with the radiotherapy and chemotherapy is witnessing a significant growth. However, increasing use of radiotherapy to treat various cancers is resulting in the fibrosarcoma. This is leading to the growth in the research activities to find out an effective way to treat cancer.

Market Taxonomy

Treatment Type

End User

Distribution Channel

Chemotherapy

Hospitals

Hospital Pharmacy

Radiation Therapy

Clinics

Retail Pharmacy

Surgery

Specialized Cancer Treatment Centers

E-Commerce

Other Therapy

Other End Users

Other Distribution Formats

(Additional information, including cross-sectional data and country-wise analysis & forecast is available in the report)

Chemotherapy to Emerge as the Highly Preferred Treatment Type

Among various treatment types such as radiation therapy, surgery, and others, chemotherapy is likely to emerge as the highly preferred treatment for fibrosarcoma. Chemotherapy is estimated to surpass US$ 100 million by 2026 end. A chemotherapy is done before surgery in case if the cancer is large but has not spread. This helps in reducing fibrosarcoma and also helps in avoiding much surgery.

Hospitals to Gain Maximum Revenue Share

Hospitals are likely to witness the highest growth between 2017 and 2026.  Hospitals are estimated to gain nearly two-fifth of the revenue share by 2017 end. Hospitals are also estimated to create an incremental opportunity of nearly US$ 100 million between 2017 and 2026. Increasing investment by governments in various countries towards the development of healthcare infrastructure is contributing towards the significant growth of the hospitals with technically advanced treatments.

Hospital Pharmacy to Emerge as One of the Largest Distributors

Hospital pharmacy is likely to be one of the largest distribution channels in the global fibrosarcoma market during 2017-2026. Hospital pharmacy is projected to bring in nearly US$ 200 million revenue towards 2026 end. Hospital pharmacy in many countries is emerging as the biggest distributors of the drugs used in treating cancer. Moreover, availability of various drugs and government support are also resulting in the growth of the hospital pharmacy as a distribution channel. 

Competition Tracking

The report offers information on the key companies that are likely to play an active role in the expansion of global fibrosarcoma market through 2026, which include Cadila Pharmaceuticals Limited, Celon Laboratories Limited, Bristol-Myers Squibb Company, Dr. Reddy's Laboratories Limited, Sun Pharmaceutical Industries Limited, Novartis AG, Baxter International Inc., Eli Lilly and Company, Pfizer Inc., and Johnson & Johnson.

NoteThe insights mentioned here are of the respective analysts, and do not reflect the position of Fact.M

1. Global Economic Outlook

2. Global Fibrosarcoma Market - Executive Summary

3. Global Fibrosarcoma Market Overview
3.1. Introduction
       3.1.1. Global Fibrosarcoma Market Taxonomy
       3.1.2. Global Fibrosarcoma Market Definition
3.2. Global Fibrosarcoma Market Size (US$ Mn) and Forecast, 2012-2026
       3.2.1. Global Fibrosarcoma Market Y-o-Y Growth
3.3. Global Fibrosarcoma Market Dynamics
3.4. Supply Chain
3.5. Cost Structure
3.6. Pricing Analysis
3.7. Drug Pipeline Assessment
3.8. PESTL Analysis
3.9. Product Life Cycle

4. Global Fibrosarcoma Market Analysis and Forecast 2012-2026 
4.1. Global Fibrosarcoma Market Size and Forecast By Treatment Type, 2012-2026
       4.1.1. Chemotherapy Market Size and Forecast, 2012-2026
                4.1.1.1. Revenue (US$ Mn) Comparison, By Region
                4.1.1.2. Market Share Comparison, By Region
                4.1.1.3. Y-o-Y growth Comparison, By Region
       4.1.2. Radiation Therapy Market Size and Forecast, 2012-2026
                4.1.2.1. Revenue (US$ Mn) Comparison, By Region
                4.1.2.2. Market Share Comparison, By Region
                4.1.2.3. Y-o-Y growth Comparison, By Region
       4.1.3. Surgery Market Size and Forecast, 2012-2026
                4.1.3.1. Revenue (US$ Mn) Comparison, By Region
                4.1.3.2. Market Share Comparison, By Region
                4.1.3.3. Y-o-Y growth Comparison, By Region
       4.1.4. Other Therapy Market Size and Forecast, 2012-2026
                4.1.4.1. Revenue (US$ Mn) Comparison, By Region
                4.1.4.2. Market Share Comparison, By Region
                4.1.4.3. Y-o-Y growth Comparison, By Region
4.2. Global Fibrosarcoma Market Size and Forecast By End User, 2012-2026
       4.2.1. Hospitals Market Size and Forecast, 2012-2026
                4.2.1.1. Revenue (US$ Mn) Comparison, By Region
                4.2.1.2. Market Share Comparison, By Region
                4.2.1.3. Y-o-Y growth Comparison, By Region
       4.2.2. Clinics Market Size and Forecast, 2012-2026
                4.2.2.1. Revenue (US$ Mn) Comparison, By Region
                4.2.2.2. Market Share Comparison, By Region
                4.2.2.3. Y-o-Y growth Comparison, By Region
       4.2.3. Specialized Cancer Treatment Centers Market Size and Forecast, 2012-2026
                4.2.3.1. Revenue (US$ Mn) Comparison, By Region
                4.2.3.2. Market Share Comparison, By Region
                4.2.3.3. Y-o-Y growth Comparison, By Region
       4.2.4. Other End Users Market Size and Forecast, 2012-2026
                4.2.4.1. Revenue (US$ Mn) Comparison, By Region
                4.2.4.2. Market Share Comparison, By Region
                4.2.4.3. Y-o-Y growth Comparison, By Region
4.3. Global Fibrosarcoma Market Size and Forecast By Distribution Channel, 2012-2026
       4.3.1. Hospital Pharmacy Market Size and Forecast, 2012-2026
                4.3.1.1. Revenue (US$ Mn) Comparison, By Region
                4.3.1.2. Market Share Comparison, By Region
                4.3.1.3. Y-o-Y growth Comparison, By Region
       4.3.2. Retail Pharmacy  Market Size and Forecast, 2012-2026
                4.3.2.1. Revenue (US$ Mn) Comparison, By Region
                4.3.2.2. Market Share Comparison, By Region
                4.3.2.3. Y-o-Y growth Comparison, By Region
       4.3.3. E-Commerce Market Size and Forecast, 2012-2026
                4.3.3.1. Revenue (US$ Mn) Comparison, By Region
                4.3.3.2. Market Share Comparison, By Region
                4.3.3.3. Y-o-Y growth Comparison, By Region
       4.3.4. Other Distribution Formats Market Size and Forecast, 2012-2026
                4.3.4.1. Revenue (US$ Mn) Comparison, By Region
                4.3.4.2. Market Share Comparison, By Region
                4.3.4.3. Y-o-Y growth Comparison, By Region

5. North America Fibrosarcoma Market Size and Forecast, 2012-2026
5.1. North America Outlook 
5.2. North America Parent Market Outlook 
5.3. North America Target Market Outlook 
5.4. Revenue (US$ Mn) Comparison, By Country 
       5.4.1. US Market Size and Forecast (US$ Mn), 2012-2026
       5.4.2. Canada Market Size and Forecast (US$ Mn), 2012-2026
5.5. Revenue (US$ Mn) Comparison, By Treatment Type 
5.6. Revenue (US$ Mn) Comparison, By End User 
5.7. Revenue (US$ Mn) Comparison, By Distribution Channel 

6. Latin America Fibrosarcoma Market Size and Forecast, 2012-2026
6.1. Latin America Outlook 
6.2. Latin America Parent Market Outlook 
6.3. Latin America Target Market Outlook 
6.4. Revenue (US$ Mn) Comparison, By Country 
       6.4.1. Brazil Market Size and Forecast (US$ Mn), 2012-2026
       6.4.2. Mexico Market Size and Forecast (US$ Mn), 2012-2026
       6.4.3. Rest of Latin America Market Size and Forecast (US$ Mn), 2012-2026
6.5. Revenue (US$ Mn) Comparison, By Treatment Type 
6.6. Revenue (US$ Mn) Comparison, By End User 
6.7. Revenue (US$ Mn) Comparison, By Distribution Channel 

7. Europe Fibrosarcoma Market Size and Forecast, 2012-2026
7.1. Europe Outlook 
7.2. Europe Parent Market Outlook 
7.3. Europe Target Market Outlook 
7.4. Revenue (US$ Mn) Comparison, By Country 
       7.4.1. Germany Market Size and Forecast (US$ Mn), 2012-2026
       7.4.2. UK Market Size and Forecast (US$ Mn), 2012-2026
       7.4.3. France Market Size and Forecast (US$ Mn), 2012-2026
       7.4.4. Spain Market Size and Forecast (US$ Mn), 2012-2026
       7.4.5. Italy Market Size and Forecast (US$ Mn), 2012-2026
       7.4.6. Rest of Europe Market Size and Forecast (US$ Mn), 2012-2026
7.5. Revenue (US$ Mn) Comparison, By Treatment Type 
7.6. Revenue (US$ Mn) Comparison, By End User 
7.7. Revenue (US$ Mn) Comparison, By Distribution Channel 

8. Japan Fibrosarcoma Market Size and Forecast, 2012-2026
8.1. Japan Outlook 
8.2. Japan Parent Market Outlook 
8.3. Japan Target Market Outlook 
8.4. Revenue (US$ Mn) Comparison, By Country 
       8.4.1. Japan  Market Size and Forecast (US$ Mn), 2012-2026
8.5. Revenue (US$ Mn) Comparison, By Treatment Type 
8.6. Revenue (US$ Mn) Comparison, By End User 
8.7. Revenue (US$ Mn) Comparison, By Distribution Channel 

9. APEJ Fibrosarcoma Market Size and Forecast, 2012-2026
9.1. APEJ Outlook 
9.2. APEJ Parent Market Outlook 
9.3. APEJ Target Market Outlook 
9.4. Revenue (US$ Mn) Comparison, By Country 
       9.4.1. China Market Size and Forecast (US$ Mn), 2012-2026
       9.4.2. India Market Size and Forecast (US$ Mn), 2012-2026
       9.4.3. Thailand Market Size and Forecast (US$ Mn), 2012-2026
       9.4.4. Singapore Market Size and Forecast (US$ Mn), 2012-2026
       9.4.5. Australia Market Size and Forecast (US$ Mn), 2012-2026
       9.4.6. Rest of APEJ Market Size and Forecast (US$ Mn), 2012-2026
9.5. Revenue (US$ Mn) Comparison, By Treatment Type 
9.6. Revenue (US$ Mn) Comparison, By End User 
9.7. Revenue (US$ Mn) Comparison, By Distribution Channel 

10. MEA Fibrosarcoma Market Size and Forecast, 2012-2026
10.1. MEA Outlook 
10.2. MEA Parent Market Outlook 
10.3. MEA Target Market Outlook 
10.4. Revenue (US$ Mn) Comparison, By Country 
       10.4.1. GCC Countries Market Size and Forecast (US$ Mn), 2012-2026
       10.4.2. South Africa Market Size and Forecast (US$ Mn), 2012-2026
       10.4.3. Nigeria Market Size and Forecast (US$ Mn), 2012-2026
       10.4.4. Rest of MEA Market Size and Forecast (US$ Mn), 2012-2026
10.5. Revenue (US$ Mn) Comparison, By Treatment Type 
10.6. Revenue (US$ Mn) Comparison, By End User 
10.7. Revenue (US$ Mn) Comparison, By Distribution Channel 

11. Global Fibrosarcoma Market Company Share, Competition Landscape and Company Profiles
11.1. Company Share Analysis
11.2. Competition Landscape
11.3. Company Profiles
       11.3.1. Johnson & Johnson
       11.3.2. Pfizer Inc
       11.3.3. Eli Lilly and Company
       11.3.4. Baxter International Inc
       11.3.5. Novartis AG
       11.3.6. Sun Pharmaceutical Industries Limited
       11.3.7. Dr. Reddy's Laboratories Limited
       11.3.8. Bristol-Myers Squibb Company
       11.3.9. Celon Laboratories Limited
       11.3.10. Cadila Pharmaceuticals Limited

12. Research Methodology

13. Secondary and Primary Sources

14. Assumptions and Acronyms

15. Disclaimer

TABLE 1 Global Fibrosarcoma Market Value (US$ Mn), 2012-2017
TABLE 2 Global Fibrosarcoma Market Value (US$ Mn), 2018-2026
TABLE 3 Global Fibrosarcoma Market Value (US$ Mn) and Y-o-Y, 2017-2026
TABLE 4 Global Chemotherapy Segment Value (US$ Mn), By Region 2012-2017
TABLE 5 Global Chemotherapy Segment Value (US$ Mn), By Region 2018-2026
TABLE 6 Global Chemotherapy Segment Market Share, By Region 2012-2017
TABLE 7 Global Chemotherapy Segment Market Share, By Region 2018-2026
TABLE 8 Global Chemotherapy Segment Y-o-Y, By Region 2017-2026
TABLE 9 Global Radiation Therapy Segment Value (US$ Mn), By Region 2012-2017
TABLE 10 Global Radiation Therapy Segment Value (US$ Mn), By Region 2018-2026
TABLE 11 Global Radiation Therapy Segment Market Share, By Region 2012-2017
TABLE 12 Global Radiation Therapy Segment Market Share, By Region 2018-2026
TABLE 13 Global Radiation Therapy Segment Y-o-Y, By Region 2017-2026
TABLE 14 Global Surgery Segment Value (US$ Mn), By Region 2012-2017
TABLE 15 Global Surgery Segment Value (US$ Mn), By Region 2018-2026
TABLE 16 Global Surgery Segment Market Share, By Region 2012-2017
TABLE 17 Global Surgery Segment Market Share, By Region 2018-2026
TABLE 18 Global Surgery Segment Y-o-Y, By Region 2017-2026
TABLE 19 Global Other Therapy Segment Value (US$ Mn), By Region 2012-2017
TABLE 20 Global Other Therapy Segment Value (US$ Mn), By Region 2018-2026
TABLE 21 Global Other Therapy Segment Market Share, By Region 2012-2017
TABLE 22 Global Other Therapy Segment Market Share, By Region 2018-2026
TABLE 23 Global Other Therapy Segment Y-o-Y, By Region 2017-2026
TABLE 24 Global Hospitals Segment Value (US$ Mn), By Region 2012-2017
TABLE 25 Global Hospitals Segment Value (US$ Mn), By Region 2018-2026
TABLE 26 Global Hospitals Segment Market Share, By Region 2012-2017
TABLE 27 Global Hospitals Segment Market Share, By Region 2018-2026
TABLE 28 Global Hospitals Segment Y-o-Y, By Region 2017-2026
TABLE 29 Global Clinics Segment Value (US$ Mn), By Region 2012-2017
TABLE 30 Global Clinics Segment Value (US$ Mn), By Region 2018-2026
TABLE 31 Global Clinics Segment Market Share, By Region 2012-2017
TABLE 32 Global Clinics Segment Market Share, By Region 2018-2026
TABLE 33 Global Clinics Segment Y-o-Y, By Region 2017-2026
TABLE 34 Global Specialized Cancer Treatment Centers Segment Value (US$ Mn), By Region 2012-2017
TABLE 35 Global Specialized Cancer Treatment Centers Segment Value (US$ Mn), By Region 2018-2026
TABLE 36 Global Specialized Cancer Treatment Centers Segment Market Share, By Region 2012-2017
TABLE 37 Global Specialized Cancer Treatment Centers Segment Market Share, By Region 2018-2026
TABLE 38 Global Specialized Cancer Treatment Centers Segment Y-o-Y, By Region 2017-2026
TABLE 39 Global Other End Users Segment Value (US$ Mn), By Region 2012-2017
TABLE 40 Global Other End Users Segment Value (US$ Mn), By Region 2018-2026
TABLE 41 Global Other End Users Segment Market Share, By Region 2012-2017
TABLE 42 Global Other End Users Segment Market Share, By Region 2018-2026
TABLE 43 Global Other End Users Segment Y-o-Y, By Region 2017-2026
TABLE 44 Global Hospital Pharmacy Segment Value (US$ Mn), By Region 2012-2017
TABLE 45 Global Hospital Pharmacy Segment Value (US$ Mn), By Region 2018-2026
TABLE 46 Global Hospital Pharmacy Segment Market Share, By Region 2012-2017
TABLE 47 Global Hospital Pharmacy Segment Market Share, By Region 2018-2026
TABLE 48 Global Hospital Pharmacy Segment Y-o-Y, By Region 2017-2026
TABLE 49 Global Retail Pharmacy Segment Value (US$ Mn), By Region 2012-2017
TABLE 50 Global Retail Pharmacy Segment Value (US$ Mn), By Region 2018-2026
TABLE 51 Global Retail Pharmacy Segment Market Share, By Region 2012-2017
TABLE 52 Global Retail Pharmacy Segment Market Share, By Region 2018-2026
TABLE 53 Global Retail Pharmacy Segment Y-o-Y, By Region 2017-2026
TABLE 54 Global E-Commerce Segment Value (US$ Mn), By Region 2012-2017
TABLE 55 Global E-Commerce Segment Value (US$ Mn), By Region 2018-2026
TABLE 56 Global E-Commerce Segment Market Share, By Region 2012-2017
TABLE 57 Global E-Commerce Segment Market Share, By Region 2018-2026
TABLE 58 Global E-Commerce Segment Y-o-Y, By Region 2017-2026
TABLE 59 Global Other Distribution Formats Segment Value (US$ Mn), By Region 2012-2017
TABLE 60 Global Other Distribution Formats Segment Value (US$ Mn), By Region 2018-2026
TABLE 61 Global Other Distribution Formats Segment Market Share, By Region 2012-2017
TABLE 62 Global Other Distribution Formats Segment Market Share, By Region 2018-2026
TABLE 63 Global Other Distribution Formats Segment Y-o-Y, By Region 2017-2026
TABLE 64 North America Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 65 North America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 66 North America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 67 North America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 68 North America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 69 North America Fibrosarcoma Market Value (US$ Mn), By Country 2012-2017
TABLE 70 North America Fibrosarcoma Market Value (US$ Mn), By Country 2018-2026
TABLE 71 North America Fibrosarcoma Market Value (US$ Mn), By Treatment Type 2012-2017
TABLE 72 North America Fibrosarcoma Market Value (US$ Mn), By Treatment Type 2018-2026
TABLE 73 North America Fibrosarcoma Market Value (US$ Mn), By End User 2012-2017
TABLE 74 North America Fibrosarcoma Market Value (US$ Mn), By End User 2018-2026
TABLE 75 North America Fibrosarcoma Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 76 North America Fibrosarcoma Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 77 Latin America Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 78 Latin America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 79 Latin America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 80 Latin America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 81 Latin America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 82 Latin America Fibrosarcoma Market Value (US$ Mn), By Country 2012-2017
TABLE 83 Latin America Fibrosarcoma Market Value (US$ Mn), By Country 2018-2026
TABLE 84 Latin America Fibrosarcoma Market Value (US$ Mn), By Treatment Type 2012-2017
TABLE 85 Latin America Fibrosarcoma Market Value (US$ Mn), By Treatment Type 2018-2026
TABLE 86 Latin America Fibrosarcoma Market Value (US$ Mn), By End User 2012-2017
TABLE 87 Latin America Fibrosarcoma Market Value (US$ Mn), By End User 2018-2026
TABLE 88 Latin America Fibrosarcoma Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 89 Latin America Fibrosarcoma Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 90 Europe Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 91 Europe Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 92 Europe Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 93 Europe Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 94 Europe Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 95 Europe Fibrosarcoma Market Value (US$ Mn), By Country 2012-2017
TABLE 96 Europe Fibrosarcoma Market Value (US$ Mn), By Country 2018-2026
TABLE 97 Europe Fibrosarcoma Market Value (US$ Mn), By Treatment Type 2012-2017
TABLE 98 Europe Fibrosarcoma Market Value (US$ Mn), By Treatment Type 2018-2026
TABLE 99 Europe Fibrosarcoma Market Value (US$ Mn), By End User 2012-2017
TABLE 100 Europe Fibrosarcoma Market Value (US$ Mn), By End User 2018-2026
TABLE 101 Europe Fibrosarcoma Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 102 Europe Fibrosarcoma Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 103 Japan Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 104 Japan Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 105 Japan Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 106 Japan Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 107 Japan Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 108 Japan Fibrosarcoma Market Value (US$ Mn), By Country 2012-2017
TABLE 109 Japan Fibrosarcoma Market Value (US$ Mn), By Country 2018-2026
TABLE 110 Japan Fibrosarcoma Market Value (US$ Mn), By Treatment Type 2012-2017
TABLE 111 Japan Fibrosarcoma Market Value (US$ Mn), By Treatment Type 2018-2026
TABLE 112 Japan Fibrosarcoma Market Value (US$ Mn), By End User 2012-2017
TABLE 113 Japan Fibrosarcoma Market Value (US$ Mn), By End User 2018-2026
TABLE 114 Japan Fibrosarcoma Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 115 Japan Fibrosarcoma Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 116 APEJ Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 117 APEJ Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 118 APEJ Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 119 APEJ Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 120 APEJ Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 121 APEJ Fibrosarcoma Market Value (US$ Mn), By Country 2012-2017
TABLE 122 APEJ Fibrosarcoma Market Value (US$ Mn), By Country 2018-2026
TABLE 123 APEJ Fibrosarcoma Market Value (US$ Mn), By Treatment Type 2012-2017
TABLE 124 APEJ Fibrosarcoma Market Value (US$ Mn), By Treatment Type 2018-2026
TABLE 125 APEJ Fibrosarcoma Market Value (US$ Mn), By End User 2012-2017
TABLE 126 APEJ Fibrosarcoma Market Value (US$ Mn), By End User 2018-2026
TABLE 127 APEJ Fibrosarcoma Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 128 APEJ Fibrosarcoma Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 129 MEA Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 130 MEA Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 131 MEA Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 132 MEA Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 133 MEA Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 134 MEA Fibrosarcoma Market Value (US$ Mn), By Country 2012-2017
TABLE 135 MEA Fibrosarcoma Market Value (US$ Mn), By Country 2018-2026
TABLE 136 MEA Fibrosarcoma Market Value (US$ Mn), By Treatment Type 2012-2017
TABLE 137 MEA Fibrosarcoma Market Value (US$ Mn), By Treatment Type 2018-2026
TABLE 138 MEA Fibrosarcoma Market Value (US$ Mn), By End User 2012-2017
TABLE 139 MEA Fibrosarcoma Market Value (US$ Mn), By End User 2018-2026
TABLE 140 MEA Fibrosarcoma Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 141 MEA Fibrosarcoma Market Value (US$ Mn), By Distribution Channel 2018-2026

FIG. 1 Global Fibrosarcoma Market Value (US$ Mn), 2012-2017
FIG. 2 Global Fibrosarcoma Market Value (US$ Mn) Forecast, 2018-2026
FIG. 3 Global Fibrosarcoma Market Value (US$ Mn) and Y-o-Y, 2017-2026
FIG. 4 Global Chemotherapy Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 5 Global Chemotherapy Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 6 Global Chemotherapy Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 7 Global Radiation Therapy Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 8 Global Radiation Therapy Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 9 Global Radiation Therapy Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 10 Global Surgery Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 11 Global Surgery Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 12 Global Surgery Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 13 Global Other Therapy Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 14 Global Other Therapy Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 15 Global Other Therapy Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 16 Global Hospitals Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 17 Global Hospitals Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 18 Global Hospitals Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 19 Global Clinics Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 20 Global Clinics Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 21 Global Clinics Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 22 Global Specialized Cancer Treatment Centers Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 23 Global Specialized Cancer Treatment Centers Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 24 Global Specialized Cancer Treatment Centers Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 25 Global Other End Users Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 26 Global Other End Users Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 27 Global Other End Users Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 28 Global Hospital Pharmacy Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 29 Global Hospital Pharmacy Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 30 Global Hospital Pharmacy Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 31 Global Retail Pharmacy Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 32 Global Retail Pharmacy Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 33 Global Retail Pharmacy Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 34 Global E-Commerce Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 35 Global E-Commerce Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 36 Global E-Commerce Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 37 Global Other Distribution Formats Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 38 Global Other Distribution Formats Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 39 Global Other Distribution Formats Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 40 North America Fibrosarcoma Market Value (US$ Mn), By Country 2012-2017
FIG. 41 North America Fibrosarcoma Market Value (US$ Mn), By Country 2018-2026
FIG. 42 North America Fibrosarcoma Market Value (US$ Mn), By Treatment Type 2012-2017
FIG. 43 North America Fibrosarcoma Market Value (US$ Mn), By Treatment Type 2018-2026
FIG. 44 North America Fibrosarcoma Market Value (US$ Mn), By End User 2012-2017
FIG. 45 North America Fibrosarcoma Market Value (US$ Mn), By End User 2018-2026
FIG. 46 North America Fibrosarcoma Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 47 North America Fibrosarcoma Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 48 Latin America Fibrosarcoma Market Value (US$ Mn), By Country 2012-2017
FIG. 49 Latin America Fibrosarcoma Market Value (US$ Mn), By Country 2018-2026
FIG. 50 Latin America Fibrosarcoma Market Value (US$ Mn), By Treatment Type 2012-2017
FIG. 51 Latin America Fibrosarcoma Market Value (US$ Mn), By Treatment Type 2018-2026
FIG. 52 Latin America Fibrosarcoma Market Value (US$ Mn), By End User 2012-2017
FIG. 53 Latin America Fibrosarcoma Market Value (US$ Mn), By End User 2018-2026
FIG. 54 Latin America Fibrosarcoma Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 55 Latin America Fibrosarcoma Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 56 Europe Fibrosarcoma Market Value (US$ Mn), By Country 2012-2017
FIG. 57 Europe Fibrosarcoma Market Value (US$ Mn), By Country 2018-2026
FIG. 58 Europe Fibrosarcoma Market Value (US$ Mn), By Treatment Type 2012-2017
FIG. 59 Europe Fibrosarcoma Market Value (US$ Mn), By Treatment Type 2018-2026
FIG. 60 Europe Fibrosarcoma Market Value (US$ Mn), By End User 2012-2017
FIG. 61 Europe Fibrosarcoma Market Value (US$ Mn), By End User 2018-2026
FIG. 62 Europe Fibrosarcoma Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 63 Europe Fibrosarcoma Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 64 Japan Fibrosarcoma Market Value (US$ Mn), By Country 2012-2017
FIG. 65 Japan Fibrosarcoma Market Value (US$ Mn), By Country 2018-2026
FIG. 66 Japan Fibrosarcoma Market Value (US$ Mn), By Treatment Type 2012-2017
FIG. 67 Japan Fibrosarcoma Market Value (US$ Mn), By Treatment Type 2018-2026
FIG. 68 Japan Fibrosarcoma Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 69 Japan Fibrosarcoma Market Value (US$ Mn), By End User 2018-2026
FIG. 70 Japan Fibrosarcoma Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 71 Japan Fibrosarcoma Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 72 APEJ Fibrosarcoma Market Value (US$ Mn), By Country 2012-2017
FIG. 73 APEJ Fibrosarcoma Market Value (US$ Mn), By Country 2018-2026
FIG. 74 APEJ Fibrosarcoma Market Value (US$ Mn), By Treatment Type 2012-2017
FIG. 75 APEJ Fibrosarcoma Market Value (US$ Mn), By Treatment Type 2018-2026
FIG. 76 APEJ Fibrosarcoma Market Value (US$ Mn), By End User 2012-2017
FIG. 77 APEJ Fibrosarcoma Market Value (US$ Mn), By End User 2018-2026
FIG. 78 APEJ Fibrosarcoma Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 79 APEJ Fibrosarcoma Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 80 MEA Fibrosarcoma Market Value (US$ Mn), By Country 2012-2017
FIG. 81 MEA Fibrosarcoma Market Value (US$ Mn), By Country 2018-2026
FIG. 82 MEA Fibrosarcoma Market Value (US$ Mn), By Treatment Type 2012-2017
FIG. 83 MEA Fibrosarcoma Market Value (US$ Mn), By Treatment Type 2018-2026
FIG. 84 MEA Fibrosarcoma Market Value (US$ Mn), By End User 2012-2017
FIG. 85 MEA Fibrosarcoma Market Value (US$ Mn), By End User 2018-2026
FIG. 86 MEA Fibrosarcoma Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 87 MEA Fibrosarcoma Market Value (US$ Mn), By Distribution Channel 2018-2026

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Benefits of Becoming a Fact.MR Client

  • Access to our global market coverage
  • Periodic updates on your sector
  • Exclusive discounts and offers
  • Greater flexibility for customization
  • Quick-research assistance for ad-hoc needs
  • Access to credible insights Fact.MR analyst interactions
  • Access to Fact.MR tools and research to fuel strategy development